Premenstrual dysphoric disorder: Approach and treatment;Trouble dysphorique prémenstruel: Approche et traitement

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 1, 2003, Pages 49-54

  Bianchi Demicheli, F ^a   Ludicke F ^a   Campana, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

ALPHA TOCOPHEROL; ALPRAZOLAM; BROMOCRIPTINE; BUSERELIN; CITALOPRAM; DANAZOL; FLUOXETINE; GOSERELIN; LEUPRORELIN; MELATONIN; PAROXETINE; PRIMROSE OIL; PYRIDOXINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; DEPRESSION; DIET; FEMALE; FOLLICULAR PHASE; HUMAN; INCIDENCE; LETHARGY; LUTEAL PHASE; MENSTRUAL CYCLE; MENTAL INSTABILITY; MINERAL INTAKE; PATHOGENESIS; PHYSICAL ACTIVITY; PREMENSTRUAL DYSPHORIC DISORDER; PSYCHOTHERAPY;

EID: 0344406667     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(02)00007-3     Document Type: Article

References (52)

1. Dalton K. Schoolgirls' behavior and menstruation. BMJ 1960:1647-9.
2. Dalton K. Menstruation and crime. BMJ 1961:1752-3.
3. Greene R, Dalton K. The premenstrual syndrome. BMJ 1953:1007-14.
4. DSM IV. Diagnostic and statistical manual of mental disorders. Paris: Masson; 1996.
5. Pearlstein T, Stone AB. Premenstrual syndrome. Psychiatr Clin North Am 1998;21:577-90.
6. Mimoun S. Traité de gynécologie-obstétrique psychosomatique. Paris: Masson; 1999.
7. Hendrick V, Altshuler LL. Recurrent mood shifts of premenstrual dysphoric disorder can be mistaken for rapid-cycling bipolar II disorder. J Clin Psychiatry 1998;59:479-80.
8. Roy-Byrne PP, Rubinow DR, Gwirtsman H, Hoban MC, Grover GN. Cortisol response to dexamethasone in women with premenstrual syndrome. Neuropsychobiology 1986;16:61-3.
9. Roy-Byrne PP, Rubinow DR, Hoban MC, Parry BL, Rosenthal NE, Nurnberger JI, et al. Premenstrual changes: a comparison of five populations. Psychiatry Res 1986;17:77-85.
10. Shafii M, Shafii SL. Melatonin, light therapyand premenstrual syndrome. Am psychiat Press Inc 1990:177-9.
11. Schagen van Leeuwen JH, te Velde ER, Koppeschaar HP, Kop WJ, Thijssen JH, van Ree JM, et al. Is premenstrual syndrome an endocrine disorder? J Psychosom Obstet Gynaecol 1993;14:91-109.
12. Menkes DB, Taghavi E, Mason PA, Spears GF, Howard RC. Fluoxetine treatment of severe premenstrual syndrome. BMJ 1992;305:346-7.
13. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994;55:332-5.
14. Pearlstein TB, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 1997;17:261-6.
15. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. Fluoxetine in the treatment of premenstrual dysphoria, Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 1995;332:1529-34.
16. Stewart DE, Fairman M, Barbadoro S, Zownir P, Steiner M. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder. Biol Psychiatry 1994;36:201-2.
17. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of premenstrual syndrome. Psychopharmacol Bull 1990;26:331-5.
18. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991;52:290-3.
19. Su TP, Schmidt PJ, Danaceau MA, Tobin MB, Rosenstein DL, Murphy DL, Rubinow DR. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 1997;16:346-56.
20. Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial. J Clin Psychiatry 1996;57:7-11.
21. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 1999;56:932-9.
22. Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.
23. Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996;16:3-8.
24. Young SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 1998;59:76-80.
25. Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995;12:167-76.
26. Sundblad C, Wikander I, Andersch B, Eriksson E. A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. Eur Neuropsychopharmacol 1997;7:201-6.
27. Mortola JF. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Saf 1994;10:160-9.
28. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998;18:390-8.
29. Daamen MJ, Brown WA. Single-dose fluoxetine in management of premenstrual syndrome. J Clin Psychiatry 1992;53:210-1.
30. Steiner M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 1997;33:771-4.
31. Evans SM, Haney M, Levin FR, Foltin RW, Fischman MW. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharmacology 1998;19:499-516.
32. Rickels K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome. Lancet 1989;1:777.
33. Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997;33:303-9.
34. Deeny M, Hawthorn R, McKay HD. Low dose danazol in the treatment of the premenstrual syndrome. Postgrad Med J 1991;67:450-4.
35. Gilmore DH, Hawthorn RJ, Hart DM. Danol for premenstrual syndrome: a preliminary report of a placebo-controlled double-blind study. J Int Med Res 1985;13:129-30.
36. Sarno AP, Miller EJ, Lundblad EG. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 1987;70:33-6.
37. Watts JF, Edwards RL, Butt WR. Treatment of premenstrual syndrome using danazol: preliminary report of a placebo-controlled, double-blind, dose ranging study. J Int Med Res 1985;13:127-8.
38. Watts JF, Butt WR, Logan ER. A clinical trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol 1987;94:30-4.
39. Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of the premenstrual syndrome-a review. Br J Obstet Gynaecol 1990;97:847-52.
40. London RS, Sundaram GS, Murphy L, Goldstein PJ. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. J Am Coll Nutr 1983;2:115-22.
41. London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987;32:400-4.
42. Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol 1984;150:363-6.
43. Budeiri D, Li Wan PA, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996;17:60-8.
44. Andersch B. Bromocriptine and premenstrual symptoms: a survey of double blind trials. Obstet Gynecol Surv 1983;38:643-6.
45. Penland JG, Johnson PE. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993;168:1417-23.
46. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms, Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998;179:444-52.
47. Johnson SR. Premenstrual syndrome therapy. Clin Obstet Gynecol 1998;41:405-21.
48. Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol 1989; 161:1228-34.
49. Woods NF, Most A, Longenecker GD. Major life events, daily stressors, and perimenstrual symptoms. Nurs Res 1985;34:263-7.
50. Morse G. Positively reframing perceptions of the menstrual cycle among women with premenstrual syndrome. J Obstet Gynecol Neonatal Nurs 1999;28:165-74.
51. Christensen AP, Oei TP. The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. J Affect Disord 1995;33:57-63.
52. Blake F, Salkovskis P, Gath D, Day A, Garrod A. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res 1998;45:307-18.